Introduction
Peribulbar block is used to obtain anaesthesia and akinesia of the eye by injecting local anaesthetic around the muscle cone. (1) There is reduced risk for globe perforation and optic nerve damage with peribulbar (extraconal) than retro bulbar (intraconal) block. The low toxicity of ropivacaine makes it attractive for peribulbar anaesthesia. However its motor sparing properties are undesirable when akinesia is important (2) . Ropivacaine is recently being introduced in Indian market and needs to be evaluated in Indian perspective. Dexamethasone is a high potent, long acting glucocorticoid with little mineralocorticoid effect. Glucocorticoid have been used to reduce inflammation and for prevention of post-operative nausea and vomiting, they are also effective in reducing post-operative pain and oedema (3) . • To compare the efficacy of 0.75% ropivacaine and 2mg dexamethasone with 0.5% bupivacaine and 2mg dexamethasone to assess the akinesia, analgesia, IOP and post op inflammation in peribulbar block.
Materials and Method
After a written informed consent from the patients, they will be randomized to receive peribulbar anaesthesia using 0.75% ropivacaine, 2mg dexamethasone and hyaluronidase 50 IU/ml in group A (n=25) or 0.5% bupivacaine, 2mg dexamethasone and hyaluronidase 50 IU/ml in group B (n=25). Standard monitoring will be established and vitals will be monitored. Data collection 1) Sample Size: 50 2) Inclusion Criteria • patient aged 50 years and above who will undergo elective surgery for uncomplicated cataract 3) Exclusion Criteria
• Patients refusing consent • Patients on anticoagulant therapy • Allergic to amide local anaesthetic or hyaluronidase • contraindication to steroids • Presence of major systemic disease or psychiatric illness and patients with single eye. The anaesthetic solution was prepared individually and immediately before the block. The investigators performing the injections and assessment will be blinded to the solution used. Peribulbar local anaesthetic will be given by using 25G, 1 inch needle at the junction of lateral 1/3 rd and medial 2/3 rd directed deliberately towards the orbital floor and the drug will be injected until peribulbar fullness was observed or to a maximum volume of In Table 2 , akinesia was achieved slower (at 14.12+/-2.99 mins) in Group II when compared to (8.24+/-1.05), Group I which was statistically significant (p<0.05).but lasted longer group II when compared to group I Table 3 shows that first rescue analgesic was taken at a longer time period in Group I(2.04+/-0.35) when compared to Group II(1.08+/-0.28) which was statistically significant (p<0.05) There was no significance between the two groups on iop changes Group I had less post op inflammation than group II which was statistically significant.
Discussion
• Our study was a prospective double blinded randomized controlled study • Primary outcome was faster onset of akinesia with bupivacaine with dexamethasone, first rescue analgesia was taken after long time interval, VAS score, post op inflammation was less in this group • Prolonged post operative akinesia was with ropivacaine with dexamethasone.
• Dexamethasone was used before intravitreally, subconjunctival injections, peribulbar block in posterior segment eye surgery, in our study we have proved that it could be given for peribulbar anaesthesia for anterior segment also.
Conclusion
• We would conclude by our study that bupivacaine with dexamethasone had good outcome when compared to ropivacaine with dexamethasone as a peribulbar block in cataract surgery.
